ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Illumina Inc

Illumina Inc (ILMN)

131.72
-1.89
(-1.41%)
Al cierre: 29 Enero 3:00PM
133.2563
1.54
( 1.17% )
Fuera de horario: 3:35PM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
133.2563
Postura de Compra
130.64
Postura de Venta
133.50
Volume Operado de la Acción
2,424,916
129.40 Rango del Día 133.20
100.085 Rango de 52 semanas 156.61
Capitalización de Mercado [m]
Precio Anterior
133.61
Precio de Apertura
133.00
Última hora de negociación
15:57:38
Volumen financiero
US$ 319,480,598
Precio Promedio Ponderado
131.7491
Volumen promedio (3 m)
2,021,236
Acciones en circulación
158,600,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-17.98
Beneficio por acción (BPA)
-7.32
turnover
4.5B
Beneficio neto
-1.16B

Acerca de Illumina Inc

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and ... Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Mostrar más

Sector
Lab Analytical Instruments
Industria
Lab Analytical Instruments
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Illumina Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker ILMN. The last closing price for Illumina was US$133.61. Over the last year, Illumina shares have traded in a share price range of US$ 100.085 to US$ 156.61.

Illumina currently has 158,600,000 shares in issue. The market capitalisation of Illumina is US$21.19 billion. Illumina has a price to earnings ratio (PE ratio) of -17.98.

Flujo de Opciones Illumina (ILMN)

Flujo General

Pesimista

Prima Neta

-581k

Calls / Puts

0.00%

Comp. / Vent.

66.67%

OTM / ITM

400.00%

Sweeps Ratio

0.00%

ILMN Últimas noticias

Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2024 and Provides Preliminary Outlook for Fiscal Year 2025

Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2024 and Provides Preliminary Outlook for Fiscal Year 2025 PR Newswire SAN DIEGO, Jan. 14, 2025 SAN...

Illumina and NVIDIA collaborate to decode biology and propel precision health

Illumina and NVIDIA collaborate to decode biology and propel precision health PR Newswire SAN DIEGO, Jan. 13, 2025 Collaboration combines Illumina's sequencing technologies and Illumina Connected...

Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples

Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples PR Newswire SAN DIEGO, Jan. 13, 2025 Study will generate a key reference data set...

Illumina to Announce Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6, 2025

Illumina to Announce Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6, 2025 PR Newswire SAN DIEGO, Jan. 9, 2025 SAN DIEGO, Jan. 9, 2025 /PRNewswire/ -- Illumina, Inc...

Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications

Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications PR Newswire SAN DIEGO, Jan. 7, 2025 Software upgrade...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-6.2437-4.47577060932139.5145.67131.641513579137.08836607CS
4-0.7437-0.555134153.06130.21609387137.83796713CS
12-22.8337-14.6285476328156.09156.14129.152021236139.9099286CS
2612.596310.4394994199120.66156.61108.811865167136.65910958CS
52-7.7137-5.47187344825140.97156.61100.0852001449127.69372171CS
156-197.5337-59.7157411046330.79371.16891698969165.27480879CS
260-181.7437-57.6964126984315555.77891447775224.09628798CS

ILMN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Illumina?
El precio actual de las acciones de Illumina es US$ 133.2563
¿Cuántas acciones de Illumina están en circulación?
Illumina tiene 158,600,000 acciones en circulación
¿Cuál es la capitalización de mercado de Illumina?
La capitalización de mercado de Illumina es USD 21.19B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Illumina?
Illumina ha negociado en un rango de US$ 100.085 a US$ 156.61 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Illumina?
El ratio precio/beneficio de Illumina es -17.98
¿Cuál es el ratio de efectivo a ventas de Illumina?
El ratio de efectivo a ventas de Illumina es 4.63
¿Cuál es la moneda de reporte de Illumina?
Illumina presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Illumina?
El último ingresos anual de Illumina es USD 4.5B
¿Cuál es el último beneficio anual de Illumina?
El último beneficio anual de Illumina es USD -1.16B
¿Cuál es la dirección registrada de Illumina?
La dirección registrada de Illumina es CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Illumina?
La dirección del sitio web de Illumina es www.illumina.com
¿En qué sector industrial opera Illumina?
Illumina opera en el sector LAB ANALYTICAL INSTRUMENTS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
OSTOstin Technology Group Company Ltd
US$ 4.99
(70.31%)
1.72M
PCSAProcessa Pharmaceuticals Inc
US$ 0.7585
(28.06%)
1.55M
HUBCWHub Cyber Security Ltd
US$ 0.037
(23.33%)
100
CARMCarisma Therapeutics Inc
US$ 0.5916
(17.22%)
4.03M
FBLGFibroBiologics Inc
US$ 1.7888
(14.67%)
2.04k
CRGXCARGO Therapeutics Inc
US$ 3.7799
(-71.34%)
1.31M
FIBKFirst Interstate BancSystem Inc
US$ 27.25
(-17.07%)
8.59k
IRWDIronwood Pharmaceuticals Inc
US$ 3.10
(-16.67%)
26.02k
MXLMaxLinear Inc
US$ 18.99
(-12.85%)
76.31k
DXSTDecent Holding Inc
US$ 1.90
(-11.95%)
252.38k
NVDANVIDIA Corporation
US$ 126.00
(1.86%)
30.12M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 26.56
(7.40%)
15.98M
TSLATesla Inc
US$ 403.00
(3.57%)
11.38M
PLUGPlug Power Inc
US$ 1.88
(0.00%)
9.72M
VCSHVanguard Short Term Corporate Bond
US$ 78.41
(0.00%)
9.57M

ILMN Discussion

Ver más
Monksdream Monksdream 4 meses hace
ILMN on an upswing
👍️0
futrcash futrcash 2 años hace
https://www.illumina.com/
👍️0
DarthYoda DarthYoda 2 años hace
Scumbag Scott Gottlieb is on the board of this company. Short it till it's dead. He should be in prison for the rest of his life.
https://www.illumina.com/company/about-us/board-of-directors.html
👍️ 1
Robbinhood101 Robbinhood101 4 años hace
Yep and I think it’s a big winner for next 5 years.
👍️0
gnolfinvestor gnolfinvestor 4 años hace
only owned stock for a few weeks ... but i don't understand why today's announcement is negative ??? anybody understand why stock is reacting poorly to a positive partnership???
👍️0
bulletproof bulletproof 4 años hace
Hello !! Anyone home? Anybody following this stock?
👍️0
BottomBounce BottomBounce 5 años hace
$ILMN Illumina (NASDAQ:ILMN) Has a New Complementary Technology Produced by Bionano Genomics (NASDAQ: $BNGO )
https://www.twst.com/news/illumina-nasdaqilmn-new-complementary-technology-produced-bionano-genomics-nasdaqbngo/
👍️0
BottomBounce BottomBounce 5 años hace
Bionano Genomics, Inc. $BNGO Takes On Illumina, Inc. $ILMN ttps://manufacturinmarket.com/2019/10/26/bionano-genomics-inc-bngo-takes-on-illumina-inc-ilmn/
👍️0
BottomBounce BottomBounce 5 años hace
$ILMN over to $BNGO Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes, which is known as cytogenetics. Its Saphyr system comprises an instrument, chip consumables, reagents, and a suite of data analysis tools. The company's Bionano prep kits and labeling kits provide the critical reagents and protocols needed to extract and label high molecular weight DNA for use with the Saphyr system; and data solutions offering includes a suite of hardware and software for end-to-end experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. It sells its products for research use applications primarily to laboratories associated with academic and governmental research institutions, as well as to pharmaceutical, biotechnology, and contract research companies in the United States and Canada, Europe, the Middle East, India, Africa, China, Japan, South Korea, Singapore, and Australia. The company was formerly known as BioNano Genomics, Inc. and changed its name to Bionano Genomics, Inc. in July 2018. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
👍️0
T695 T695 6 años hace
Watching for entry
👍️0
TREND1 TREND1 6 años hace
ILMN SPX


http://schrts.co/HapvWzvt
👍️0
TREND1 TREND1 6 años hace
Float 128.41 M

👍️0
TREND1 TREND1 6 años hace
PE Ratio 51.90


👍️0
TREND1 TREND1 6 años hace
Earnings Per Share (EPS)=5.63

👍️0
TREND1 TREND1 6 años hace
ART HILL MAR 14, 2019
👍️0
jindal jindal 6 años hace
N.p.
👍️0
shub shub 6 años hace
Thanks Jindal:
Sure hope they can make it work acceptably!
👍️0
jindal jindal 6 años hace
https://www.theguardian.com/science/2019/feb/24/the-10-minute-test-for-cancer-pioneering-methods-blood-test-detection-tumours-lung-breast-colorectal
👍️0
PennyStock Alert PennyStock Alert 7 años hace
https://www.medgadget.com/2017/10/tissue-microarray-industry-2017-global-market-growth-trends-share-and-demands-research-report.html

Analysis of Tissue Microarray Industry Key Manufacturers:

Agilent Technologies
Illumina
Protein Biotechnologies Inc
Asterand Bioscience
Pantomics Inc
Applied Microarrays
Arrayit
Phalanx Biotech
Qiagen
Takara Bio.
👍️0
shub shub 8 años hace
Thanks PT: They want you to sign up to read it though..oh well.

I just read a newsletter report on a researcher's paper that said he'd sequenced samples on ILMN's newest high throughput sequencer and then on the prior generation's sequencer and the results didn't agree.
The report said ILMN said the discrepancy was inconsequential...but...
👍️0
shub shub 8 años hace
That's very interesting!
Thanks PT.
👍️0
BlueAlien BlueAlien 8 años hace
Illumina Acquires BlueGnome

https://www.genomeweb.com/arrays/illumina-acquires-bluegnome

This link might work...

Connect the dots
👍️0
shub shub 8 años hace
It would have if the link worked for me...but a step in the right direction.
👍️0
BlueAlien BlueAlien 8 años hace
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.

12/31/2016 3,856,897 (20,258) (0.52) 665,932

http://www.nasdaq.com/symbol/ilmn/institutional-holdings

Does this work for you??
👍️0
BlueAlien BlueAlien 8 años hace
K
👍️0
shub shub 8 años hace
The totally inappropriate biblical quotation on the premier genetic sequencing companies' stock board....is "What gives me that impression".
👍️0
BlueAlien BlueAlien 8 años hace
Well almost recovered since October...

You are an opportunistic quasi-religious loonie

What gives you that impression??
👍️0
shub shub 8 años hace
This message has nothing to do with ILMN!
You are an opportunistic quasi-religious loonie
who impolitely imposes his antiquated values on innocent victims.
That's extremely offensive!
Don't do that again please...you demean the bible..
👍️0
BlueAlien BlueAlien 8 años hace
You shall not covet your neighbor’s house. You shall not covet your neighbor’s wife, or his male or female servant, his ox or donkey, or anything that belongs to your neighbor.

—?Exodus 20:17

ILMN
👍️0
shub shub 8 años hace
Just released a new series of sequencers "NovaSeq" with great advantages.
SP up to where i bought in, finally.
Many new deals and collaborations.
In many ways, this company is the genomics kingpin.
I feel kinda dumb for not buying in years ago when i first did some DD on it.
In the long run, it should be a great investment.
Wonder why this board is so dead.
👍️0
trendmkr trendmkr 8 años hace
Lead Plaintiff Sought For Class Action Lawsuit Filed Against Illumina, Inc. (NASDAQ:ILMN) http://marketexclusive.com/lead-plaintiff-sought-class-action-lawsuit-filed-illumina-inc-nasdaqilmn/55714/?icd1
👍️0
trendmkr trendmkr 8 años hace
Biotech Movers And Shakers: Vericel and Illumina http://marketexclusive.com/biotech-movers-shakers-6/33753/?icd1
👍️0
PStockPickz PStockPickz 8 años hace
.43% congrats! come on over to AMRS :)
👍️0
shub shub 8 años hace
Thanks Mike.
Sorry for our paper losses in Ilmn as well.
But we are still bringing in money and the demand for sequencing will continue to grow for years.
👍️0
PStockPickz PStockPickz 8 años hace
Sorry for your loss good luck
👍️0
shub shub 8 años hace
Yeah well, think you might live another few years?
This kind of perturbation is just noise in the long run.
The short run investing arena looks like sucker bait to me.
👍️0
PStockPickz PStockPickz 8 años hace
i hear ya, looks like exciting stuff but in regards to the chart today not so exciting
👍️0
shub shub 8 años hace
I bought more as i like to do on market over reactions.
The PPS dropped 25% because it didn't grow as fast as projected....
Not because they lost $ or major partners or lost to a newer technology.
Gene sequencing is of growing medical importance. We have the cheapest, fastest sequencing service around by far.
We have a strong R&D program.
Doesn't look boring at all!
👍️0
PStockPickz PStockPickz 8 años hace
looking for entry but too boring
👍️0
crudeoil24 crudeoil24 8 años hace
Tank city! >>> Crushed!!!!!
👍️0
PStockPickz PStockPickz 8 años hace
might be fun today..
👍️0
Impacto Impacto 9 años hace
Pretty quiet here, bought a couple days ago, lots of room to run :)
Imo
👍️0
rainbow898 rainbow898 9 años hace
Shop@Arrayit!!
👍️0
steel8000 steel8000 9 años hace
Ya I think you may be right
👍️0
dangerx dangerx 9 años hace
Maybe, but ILMN has a 40 year head start in the counting to 10,000,000,000 game. ARYC may get there soon, but it will be from counting outstanding shares rather than base pairs.
👍️0
steel8000 steel8000 9 años hace
Aryc may be worth more than Illumina someday
👍️0
steel8000 steel8000 9 años hace
Aryc may just become a devising of illumina
👍️0
sharky sharky 9 años hace
Would be a smart move IMO. ARYC has the goods. :)
👍️0
Fireman451 Fireman451 9 años hace
Steel have you heard this through the grape vine ?
👍️0
steel8000 steel8000 9 años hace
Ilmn could buyout Aryc ??????
👍️0

Su Consulta Reciente

Delayed Upgrade Clock